Method of inhibiting fibrosis with a somatostatin agonist
US6787521B2 · kind B2 · utility
8Cited by
6References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 16, 2001 |
| Grant date | Sep 7, 2004 |
| Priority date | — |
| Expiry date | Jan 16, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method of inhibiting fibrosis in a patient. The method comprises administering a therapeutically effective amount of a somatostatin, a somatostatin agonist or a pharmaceutically acceptable salt thereof to said patent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.